|
Volumn 96, Issue 2, 2002, Pages 197-199
|
Is the exclusion of children under 24 months from anthelmintic treatment justifiable?
|
Author keywords
Adverse effects; Age; Anthelmintics; Children; Children under 2 years; Clinical trial; Mebendazole; Safety; Tanzania
|
Indexed keywords
ANTHELMINTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
MEBENDAZOLE;
PLACEBO;
ACUTE RESPIRATORY TRACT DISEASE;
ARTICLE;
CHILD NUTRITION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
DIARRHEA;
DISEASE TRANSMISSION;
DOUBLE BLIND PROCEDURE;
DRUG INDICATION;
DYSENTERY;
DYSPNEA;
FEVER;
HEALTH CARE POLICY;
HELMINTHIASIS;
HUMAN;
INFANT;
MAJOR CLINICAL STUDY;
PRESCHOOL CHILD;
RANDOMIZED CONTROLLED TRIAL;
SEIZURE;
SOIL;
TANZANIA;
|
EID: 0036323056
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/S0035-9203(02)90303-2 Document Type: Article |
Times cited : (48)
|
References (11)
|